USPH Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . US Physicalrapy
USPH Stock  USD 81.25  2.99  3.55%   
US Physicalrapy's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing US Physicalrapy's valuation are provided below:
Gross Profit
164.9 M
Profit Margin
0.0595
Market Capitalization
1.2 B
Enterprise Value Revenue
1.9937
Revenue
750.9 M
We have found one hundred twenty available fundamental measures for US Physicalrapy, which can be analyzed and compared to other ratios and to its peers in the sector. Traders should compare all of US Physicalrapy latest fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The US Physicalrapy's current Market Cap is estimated to increase to about 165.1 M. The US Physicalrapy's current Enterprise Value is estimated to increase to about 151.5 M

US Physicalrapy Total Revenue

810.65 Million

Check US Physicalrapy financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among US Physicalrapy's main balance sheet or income statement drivers, such as Interest Expense of 9.7 M, Total Revenue of 810.6 M or Gross Profit of 149.6 M, as well as many indicators such as Price To Sales Ratio of 2.96, Dividend Yield of 0.0195 or PTB Ratio of 4.65. USPH financial statements analysis is a perfect complement when working with US Physicalrapy Valuation or Volatility modules.
  
Build AI portfolio with USPH Stock
Check out the analysis of US Physicalrapy Correlation against competitors.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

US Physicalrapy Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.4 B1.3 B587 M
Slightly volatile
Other Current Liabilities65.9 M62.8 M34 M
Slightly volatile
Total Current Liabilities140.4 M133.7 M60.1 M
Slightly volatile
Total Stockholder Equity590.4 M562.3 M265.8 M
Slightly volatile
Property Plant And Equipment Net200.5 M191 M75 M
Slightly volatile
Accounts Payable7.2 M6.8 M3.2 M
Slightly volatile
Cash49.9 M47.6 M31.8 M
Slightly volatile
Non Current Assets Total1.2 B1.2 B495.5 M
Slightly volatile
Cash And Short Term Investments49.9 M47.6 M31.8 M
Slightly volatile
Net Receivables103.4 M98.5 M52 M
Slightly volatile
Common Stock Shares Outstanding13 M17.3 M12.8 M
Slightly volatile
Liabilities And Stockholders Equity1.4 B1.3 B587 M
Slightly volatile
Other Current Assets12.7 M12.1 M9 M
Slightly volatile
Other Stockholder Equity312.4 M297.5 M108.9 M
Slightly volatile
Total Liabilities493.2 M469.7 M196.7 M
Slightly volatile
Property Plant And Equipment Gross305.7 M291.1 M100.6 M
Slightly volatile
Total Current Assets166.1 M158.2 M91.5 M
Slightly volatile
Short and Long Term Debt Total356.5 M339.5 M137.6 M
Slightly volatile
Non Currrent Assets Other6.2 M5.9 M2.3 M
Slightly volatile
Non Current Liabilities Total352.8 M336 M136.6 M
Slightly volatile
Short Term Debt61.4 M58.5 M21 M
Slightly volatile
Intangible Assets216.5 M206.2 M73.1 M
Slightly volatile
Good Will570.4 M600.4 M922.3 T
Slightly volatile
Common Stock Total Equity144.3 K173.7 K142.2 K
Slightly volatile
Common Stock148.6 K197.8 K146.4 K
Slightly volatile
Other Assets2.1 M1.9 M2.2 M
Pretty Stable
Long Term Debt172.1 M163.9 M76.2 M
Slightly volatile
Property Plant Equipment154.3 M146.9 M58.1 M
Slightly volatile
Current Deferred Revenue1.9 M3.3 M2.7 M
Very volatile
Other Liabilities41.5 M39.5 M16.5 M
Slightly volatile
Long Term Debt Total142 M135.2 M68.4 M
Slightly volatile
Capital Surpluse73.5 M118.1 M73.5 M
Slightly volatile
Non Current Liabilities Other22.1 M21 M6.9 M
Slightly volatile
Warrants106 M178.6 M91.1 M
Slightly volatile
Short and Long Term Debt13.3 M12.6 M4.2 M
Slightly volatile
Net Invested Capital452.3 M738.8 M372.9 M
Slightly volatile
Capital Stock172.4 K197.8 K156.4 K
Slightly volatile
Capital Lease Obligations118.5 M163 M100.5 M
Slightly volatile

US Physicalrapy Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue810.6 M772 M436.9 M
Slightly volatile
Gross Profit149.6 M142.5 M93.8 M
Slightly volatile
Other Operating Expenses734.3 M699.4 M385 M
Slightly volatile
Cost Of Revenue661 M629.5 M343.1 M
Slightly volatile
Total Operating Expenses73.3 M69.8 M41.9 M
Slightly volatile
Income Tax Expense17.6 M16.8 M12.2 M
Slightly volatile
Depreciation And Amortization22.6 M21.5 M10.9 M
Slightly volatile
Income Before Tax72.7 M69.2 M50.5 M
Slightly volatile
Selling General Administrative70.4 M67 M39.9 M
Slightly volatile
Net Income Applicable To Common Shares19.8 M33.7 M25.5 M
Slightly volatile
Net Income From Continuing Ops42.9 M52.4 M39.4 M
Slightly volatile
Non Recurring4.7 M4.9 M4.3 M
Slightly volatile
Non Operating Income Net Other2.3 M2.9 M2.5 M
Pretty Stable
Tax Provision13.6 M16.8 M13.1 M
Pretty Stable
Interest Income3.7 M3.5 M3.5 M
Slightly volatile
Reconciled Depreciation13.8 M21.5 M12 M
Slightly volatile
Extraordinary Items3.4 M3.9 M4.2 M
Slightly volatile
Selling And Marketing Expenses7.6 M8.6 M9.4 M
Slightly volatile

US Physicalrapy Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditures5.5 M10.6 M6.8 M
Slightly volatile
End Period Cash Flow49.9 M47.6 M31.8 M
Slightly volatile
Begin Period Cash Flow184.5 M175.7 M45.3 M
Slightly volatile
Depreciation22.6 M21.5 M10.9 M
Slightly volatile
Stock Based Compensation4.7 M9 M5.5 M
Slightly volatile
Dividends Paid32 M30.5 M14.3 M
Slightly volatile
Change To Netincome39.9 M38 M20.2 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.962.293.6318
Slightly volatile
Dividend Yield0.01950.02280.0167
Pretty Stable
PTB Ratio4.653.144.1704
Pretty Stable
Days Sales Outstanding63.7653.5645.7226
Pretty Stable
Book Value Per Share47.6245.3527.161
Slightly volatile
Stock Based Compensation To Revenue0.0090.01050.012
Slightly volatile
Capex To Depreciation1.060.570.7522
Pretty Stable
PB Ratio4.653.144.1704
Pretty Stable
EV To Sales2.882.723.6089
Slightly volatile
ROIC0.04750.050.0969
Slightly volatile
Payables Turnover88.6683.0122
Pretty Stable
Sales General And Administrative To Revenue0.120.09980.0986
Slightly volatile
Capex To Revenue0.01490.01570.0355
Slightly volatile
Cash Per Share2.592.472.2592
Slightly volatile
Payout Ratio0.50.90.6262
Slightly volatile
Days Payables Outstanding5.274.554.4705
Slightly volatile
Income Quality2.191.891.6469
Slightly volatile
Intangibles To Total Assets0.690.650.6559
Slightly volatile
Net Debt To EBITDA2.762.631.6272
Pretty Stable
Current Ratio1.291.362.4094
Slightly volatile
Receivables Turnover5.557.058.0327
Pretty Stable
Graham Number33.8532.2325.1119
Slightly volatile
Shareholders Equity Per Share30.6729.2118.6378
Slightly volatile
Debt To Equity0.50.690.4159
Slightly volatile
Capex Per Share0.330.550.5042
Slightly volatile
Revenue Per Share42.1240.1131.384
Slightly volatile
Interest Debt Per Share19.0218.129.8004
Slightly volatile
Debt To Assets0.220.290.1938
Slightly volatile
Short Term Coverage Ratios7.447.8446.7086
Slightly volatile
Operating Cycle63.7653.5645.7226
Pretty Stable
Price Book Value Ratio4.653.144.1704
Pretty Stable
Days Of Payables Outstanding5.274.554.4705
Slightly volatile
Dividend Payout Ratio0.50.90.6262
Slightly volatile
Pretax Profit Margin0.0880.08070.12
Slightly volatile
Ebt Per Ebit0.670.860.9639
Slightly volatile
Effective Tax Rate0.330.280.2702
Slightly volatile
Company Equity Multiplier1.492.151.9471
Slightly volatile
Long Term Debt To Capitalization0.250.260.202
Slightly volatile
Total Debt To Capitalization0.290.430.2742
Slightly volatile
Debt Equity Ratio0.50.690.4159
Slightly volatile
Quick Ratio1.291.362.4094
Slightly volatile
Net Income Per E B T0.580.510.4449
Very volatile
Cash Ratio0.390.411.1061
Slightly volatile
Days Of Sales Outstanding63.7653.5645.7226
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.961.010.9406
Slightly volatile
Price To Book Ratio4.653.144.1704
Pretty Stable
Fixed Asset Turnover3.463.6411.1996
Slightly volatile
Debt Ratio0.220.290.1938
Slightly volatile
Price Sales Ratio2.962.293.6318
Slightly volatile
Asset Turnover0.630.660.8914
Slightly volatile
Gross Profit Margin0.290.210.2278
Very volatile
Price Fair Value4.653.144.1704
Pretty Stable

US Physicalrapy Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap165.1 M157.2 M163.8 M
Slightly volatile
Enterprise Value151.5 M144.3 M150.3 M
Slightly volatile

USPH Fundamental Market Drivers

Forward Price Earnings29.3255
Cash And Short Term Investments41.4 M

USPH Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About US Physicalrapy Financial Statements

Investors use fundamental indicators, such as US Physicalrapy's revenue or net income, to determine how well the company is positioned to perform in the future. Although US Physicalrapy's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue3.3 M1.9 M
Total Revenue772 M810.6 M
Cost Of Revenue629.5 M661 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.10  0.12 
Capex To Revenue 0.02  0.01 
Revenue Per Share 40.11  42.12 
Ebit Per Revenue 0.08  0.07 

Currently Active Assets on Macroaxis

JBLJabil Circuit
MRKMerck Company
AMGNAmgen Inc
WMTWalmart Common Stock
QYLDGlobal X NASDAQ
When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:
How To Invest In USPH
Details
Is USPH Stock a good investment?
Details
What is US Physicalrapy's Net Worth?
Details
Largest Health Care Providers & Services Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of US Physicalrapy Correlation against competitors.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.236
Dividend Share
1.79
Earnings Share
2.37
Revenue Per Share
49.547
Quarterly Revenue Growth
0.173
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY